Discovery and characterisation of an antibody that selectively modulates the inhibitory activity of plasminogen activator inhibitor-1-Reference-Cited by-同舟云学术

Discovery and characterisation of an antibody that selectively modulates the inhibitory activity of plasminogen activator inhibitor-1

Published:2019-02-07 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Vousden Katherine A.,Lundqvist Tomas,Popovic Bojana^ORCID,Naiman Brian,Carruthers Alan M.,Newton Philip,Johnson Daniel J. D.,Pomowski Anja,Wilkinson Trevor,Dufner Patrick,de Mendez Isabelle,Mallinder Philip R.,Murray Clare,Strain Martin,Connor Jane,Murray Lynne A.,Sleeman Matthew A.,Lowe David C.,Huntington James A.,Vaughan Tristan J.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-38842-x.pdf

Reference59 articles.

1. Pannekoek, H. et al. Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family. The EMBO journal 5, 2539–2544 (1986).

2. Dupont, D. M. et al. Biochemical properties of plasminogen activator inhibitor-1. Frontiers in bioscience (Landmark edition) 14, 1337–1361 (2009).

3. Gils, A. & Declerck, P. J. The structural basis for the pathophysiological relevance of PAI-I in cardiovascular diseases and the development of potential PAI-I inhibitors. Thrombosis and haemostasis 91, 425–437, https://doi.org/10.1160/TH03-12-0764 (2004).

4. Kruithof, E. K., Tran-Thang, C. & Bachmann, F. The fast-acting inhibitor of tissue-type plasminogen activator in plasma is also the primary plasma inhibitor of urokinase. Thrombosis and haemostasis 55, 65–69 (1986).

5. Stefansson, S. & Lawrence, D. A. The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature 383, 441–443, https://doi.org/10.1038/383441a0 (1996).

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach;Circulation;2024-09-10

2. The fibrinolysis renaissance;Journal of Thrombosis and Haemostasis;2023-12

3. “Super” SERPINs—A stabilizing force against fibrinolysis in thromboinflammatory conditions;Frontiers in Cardiovascular Medicine;2023-04-19

4. Circadian rhythm of plasminogen activator inhibitor-1 and cardiovascular complications in type 2 diabetes;Frontiers in Endocrinology;2023-03-20

5. Plasminogen activator inhibitor 1 is not a major causative factor for exacerbation in a mouse model of SARS-CoV-2 infection;Scientific Reports;2023-02-22